CURE’s metastatic breast cancer page features the latest cancer news and updates on metastatic breast cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in metastatic breast cancer.
April 16th 2025
Bria-IMT plus check point inhibitors had a median overall survival which outperformed that of antibody-drug conjugates in HR+ metastatic breast cancer.
PARP Inhibitor May Prolong Survival in Metastatic, BRCA-positive Breast Cancer
August 21st 2018Talazoparib reduced the risk for disease progression or death by 46 percent and improved quality of life compared with chemotherapy in a subgroup of women with breast cancer, according to the phase 3 EMBRACA trial results.
Half of Five-Year Survivors of Breast Cancer Are Not Receiving Recommended Post-Surgery Mammograms
May 25th 2018NCCN guidelines recommend annual mammograms to detect disease recurrence, but according to the study’s findings, women — even those who had adequate health insurance — were less likely to have their once-a-year mammogram as they became long-term survivors.
Popular Heart Medications May Curb Cardiac Toxicity in Patients With Breast Cancer
March 15th 2018Findings from a new study presented at the American College of Cardiology’s 67th Annual Scientific Session showed that adding two popular heart medications to the chemotherapy regimen may prevent heart damage from happening in these patients.
FDA Approves Frontline Verzenio for Advanced HR-Positive, HER2-Negative Breast Cancer
February 27th 2018The Food and Drug Administration (FDA) has approved Verzenio (abemaciclib) for use in combination with a hormonal therapy for initial treatment of postmenopausal women with hormone receptor (HR)-positive, HER2-negative advanced or metastatic breast cancer.